A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients
Ontology highlight
ABSTRACT: A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients
PROVIDER: PRJNA881935 | ENA |
REPOSITORIES: ENA
ACCESS DATA